Tylenol use in pregnancy is possibly associated with autism, and pregnant women should generally not take the drug unless they have serious fevers, federal officials said on Sept. 22.
The Food and Drug Administration notified doctors on Sept. 22 that using acetaminophen during pregnancy "may be associated with an increased risk of neurological conditions."
Still, recognizing that there are no alternatives for pregnant women with high fevers, doctors should use their best judgment, officials said.
A spokesperson for Kenvue, parent company of Tylenol’s manufacturer, told The Epoch Times in an email: "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers."
Kenvue was spun off from Johnson & Johnson in 2023.
Sending Notice, Updating Label
The FDA's letter told doctors that "an association between acetaminophen and autism has been described in many studies.""We now have data we cannot ignore," FDA Commissioner Dr. Marty Makary said during a Sept. 22 news briefing.
That includes a 2019 paper from U.S. researchers who analyzed cord plasma.
Makary said in the letter that "a causal relationship has not been established and there are contrary studies in the scientific literature."
The notice says doctors should consider minimizing the use of acetaminophen during pregnancy for routine, low-grade fevers, but it describes acetaminophen as the safest over-the-counter option in pregnancy for fevers.
The FDA is also initiating a labeling change for acetaminophen to provide updated information about the link between acetaminophen and autism.
Autism Treatment
Officials also said on Sept. 22 that there are enough data suggesting that a medication called leucovorin, approved for several uses, including treating colorectal cancer, can help treat autism.Folinic acid and folic acid are forms of vitamin B9. People without enough folic acid or folinic acid are deficient in folate, which is required for body functions such as producing red blood cells.
Some research has concluded that autistic children have high levels of folate receptor autoantibodies, which interfere with the transport of folate, or vitamin B9, in the body.
"I think this is a major step forward to get many children with autism treated and improve their ability to function. It is particularly groundbreaking in the fact that many do not think that autism can be treated at its core. This treatment fixes core biological deficits and therefore could be disease modifying," Frye told The Epoch Times in an email.
“Recognition by the administration that there is such a treatment gives hope to many families.”